cardiocore lab ltd Company Information
Company Number
05732513
Next Accounts
Sep 2025
Shareholders
biotelemetry inc
Group Structure
View All
Industry
Other business support service activities n.e.c.
Registered Address
ascent 1 aerospace boulevard, farnborough, GU14 6XW
Website
http://gobio.comcardiocore lab ltd Estimated Valuation
Pomanda estimates the enterprise value of CARDIOCORE LAB LTD at £2.9k based on a Turnover of £2.9k and 0.99x industry multiple (adjusted for size and gross margin).
cardiocore lab ltd Estimated Valuation
Pomanda estimates the enterprise value of CARDIOCORE LAB LTD at £7m based on an EBITDA of £961.7k and a 7.25x industry multiple (adjusted for size and gross margin).
cardiocore lab ltd Estimated Valuation
Pomanda estimates the enterprise value of CARDIOCORE LAB LTD at £0 based on Net Assets of £-23.9k and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cardiocore Lab Ltd Overview
Cardiocore Lab Ltd is a live company located in farnborough, GU14 6XW with a Companies House number of 05732513. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in March 2006, it's largest shareholder is biotelemetry inc with a 100% stake. Cardiocore Lab Ltd is a established, micro sized company, Pomanda has estimated its turnover at £2.9k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cardiocore Lab Ltd Health Check
Pomanda's financial health check has awarded Cardiocore Lab Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs


2 Strong

1 Regular

4 Weak

Size
annual sales of £2.9k, make it smaller than the average company (£4.8m)
£2.9k - Cardiocore Lab Ltd
£4.8m - Industry AVG

Growth
3 year (CAGR) sales growth of -73%, show it is growing at a slower rate (6.6%)
- Cardiocore Lab Ltd
6.6% - Industry AVG

Production
with a gross margin of 99.2%, this company has a lower cost of product (38.3%)
99.2% - Cardiocore Lab Ltd
38.3% - Industry AVG

Profitability
an operating margin of 33082.3% make it more profitable than the average company (5.7%)
33082.3% - Cardiocore Lab Ltd
5.7% - Industry AVG

Employees
with 1 employees, this is below the industry average (27)
1 - Cardiocore Lab Ltd
27 - Industry AVG

Pay Structure
on an average salary of £54k, the company has an equivalent pay structure (£54k)
- Cardiocore Lab Ltd
£54k - Industry AVG

Efficiency
resulting in sales per employee of £2.9k, this is less efficient (£171.4k)
£2.9k - Cardiocore Lab Ltd
£171.4k - Industry AVG

Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Cardiocore Lab Ltd
- - Industry AVG

Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Cardiocore Lab Ltd
- - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Cardiocore Lab Ltd
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Cardiocore Lab Ltd
- - Industry AVG

Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Cardiocore Lab Ltd
- - Industry AVG
CARDIOCORE LAB LTD financials

Cardiocore Lab Ltd's latest turnover from December 2023 is £2.9 thousand and the company has net assets of -£23.9 thousand. According to their latest financial statements, Cardiocore Lab Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2,907 | 3,184 | 117,382 | 127,916 | 104,334 | 96,774 | 96,187 | 108,871 | 246,300 | ||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 23 | 10,464 | 60,799 | 61,580 | 51,484 | 48,010 | 49,284 | 57,898 | 244,186 | ||||||
Gross Profit | 2,884 | -7,280 | 56,583 | 66,336 | 52,849 | 48,763 | 46,903 | 50,972 | 2,113 | ||||||
Admin Expenses | 49,126 | ||||||||||||||
Operating Profit | -47,013 | ||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | 722,221 | -43,080 | -58,915 | -32,721 | -6,285 | -16,609 | -4,106 | -2,607 | -47,013 | ||||||
Tax | |||||||||||||||
Profit After Tax | 722,221 | -43,080 | -58,915 | -32,721 | -6,285 | -16,609 | -4,106 | -2,607 | -47,013 | ||||||
Dividends Paid | |||||||||||||||
Retained Profit | 722,221 | -43,080 | -58,915 | -32,721 | -6,285 | -16,609 | -4,106 | -2,607 | -47,013 | ||||||
Employee Costs | 54,164 | 58,722 | 48,433 | 44,991 | 44,131 | 49,897 | 197,046 | ||||||||
Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
EBITDA* | -46,287 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 41 | 161 | 926 | 1,686 | |||||||||||
Intangible Assets | |||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 41 | 162 | 927 | 1,687 | |||||||||||
Stock & work in progress | |||||||||||||||
Trade Debtors | |||||||||||||||
Group Debtors | |||||||||||||||
Misc Debtors | 6,966 | 7,892 | 14,048 | 12,371 | 12,770 | 13,157 | 11,427 | 13,231 | 6,876 | 7,239 | 6,548 | 3,535 | 4,784 | 3,884 | |
Cash | 48,345 | 24,458 | 52,348 | 36,281 | 22,265 | 86,238 | 199,117 | 313,926 | 313,245 | 42,256 | 73,622 | 69,889 | 58,921 | 5,683 | |
misc current assets | |||||||||||||||
total current assets | 55,312 | 32,351 | 66,397 | 48,653 | 35,036 | 99,396 | 210,544 | 327,158 | 320,121 | 49,495 | 80,171 | 73,424 | 63,705 | 9,568 | |
total assets | 55,312 | 32,351 | 66,397 | 48,653 | 35,036 | 99,396 | 210,544 | 327,158 | 320,121 | 49,495 | 80,212 | 73,586 | 64,632 | 11,255 | |
Bank overdraft | 877 | 8,517 | |||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | |||||||||||||||
Group/Directors Accounts | 763,820 | 696,230 | 765,989 | 634,436 | 649,092 | 686,682 | 758,213 | 783,724 | 722,154 | 370,298 | 375,019 | 346,792 | 342,565 | 291,580 | |
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 23,065 | 37,655 | 26,820 | 25,198 | 22,878 | 18,343 | 18,252 | 16,723 | 22,344 | 20,655 | 16,437 | 13,798 | 12,338 | 11,557 | 17,055 |
total current liabilities | 23,943 | 801,475 | 731,568 | 791,188 | 657,315 | 667,435 | 704,934 | 774,936 | 806,068 | 742,809 | 386,736 | 388,818 | 359,131 | 354,123 | 308,635 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | |||||||||||||||
total liabilities | 23,943 | 801,475 | 731,568 | 791,188 | 657,315 | 667,435 | 704,934 | 774,936 | 806,068 | 742,809 | 386,736 | 388,818 | 359,131 | 354,123 | 308,635 |
net assets | -23,942 | -746,163 | -699,217 | -724,791 | -608,662 | -632,399 | -605,538 | -564,392 | -478,911 | -422,689 | -337,241 | -308,606 | -285,545 | -289,491 | -297,380 |
total shareholders funds | -23,942 | -746,163 | -699,217 | -724,791 | -608,662 | -632,399 | -605,538 | -564,392 | -478,911 | -422,689 | -337,241 | -308,606 | -285,545 | -289,491 | -297,380 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | -47,013 | ||||||||||||||
Depreciation | 44 | 125 | 739 | 700 | 725 | ||||||||||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | |||||||||||||||
Debtors | -6,966 | -926 | -6,156 | 1,677 | -399 | -387 | 1,730 | -1,804 | 6,355 | -363 | 691 | 3,013 | -1,249 | 900 | 3,884 |
Creditors | |||||||||||||||
Accruals and Deferred Income | -14,590 | 10,835 | 1,622 | 2,320 | 4,535 | 91 | 1,529 | -5,621 | 1,689 | 4,218 | 2,639 | 1,460 | 781 | -5,498 | 17,055 |
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | -33,117 | ||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -763,820 | 67,590 | -69,759 | 131,553 | -14,656 | -37,590 | -71,531 | -25,511 | 61,569 | 351,856 | -4,721 | 28,227 | 4,227 | 50,985 | 291,580 |
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | -763,820 | 63,724 | 64,262 | 299,129 | -27,071 | 21,775 | 12,279 | 61,481 | 41,213 | ||||||
cash and cash equivalents | |||||||||||||||
cash | -48,345 | 23,887 | -27,890 | 16,067 | 14,017 | -63,973 | -112,879 | -114,809 | 682 | 270,989 | -31,366 | 3,734 | 10,967 | 53,238 | 5,683 |
overdraft | 877 | -8,517 | 8,517 | ||||||||||||
change in cash | -49,222 | 32,404 | -36,407 | 16,067 | 14,017 | -63,973 | -112,879 | -114,809 | 682 | 270,989 | -31,366 | 3,734 | 10,967 | 53,238 | 5,683 |
cardiocore lab ltd Credit Report and Business Information
Cardiocore Lab Ltd Competitor Analysis

Perform a competitor analysis for cardiocore lab ltd by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other micro companies, companies in GU14 area or any other competitors across 12 key performance metrics.
cardiocore lab ltd Ownership
CARDIOCORE LAB LTD group structure
Cardiocore Lab Ltd has no subsidiary companies.
Ultimate parent company
BIOTELEMETRY INC
#0168042
1 parent
CARDIOCORE LAB LTD
05732513
cardiocore lab ltd directors
Cardiocore Lab Ltd currently has 2 directors. The longest serving directors include Mrs Louise Best (Jun 2021) and Mr Mark Leftwich (Apr 2022).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Louise Best | England | 44 years | Jun 2021 | - | Director |
Mr Mark Leftwich | England | 46 years | Apr 2022 | - | Director |
P&L
December 2023turnover
2.9k
-9%
operating profit
961.7k
0%
gross margin
99.3%
-143.39%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-23.9k
-0.97%
total assets
0
-1%
cash
0
-1%
net assets
Total assets minus all liabilities
cardiocore lab ltd company details
company number
05732513
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
March 2006
age
19
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
MHA
address
ascent 1 aerospace boulevard, farnborough, GU14 6XW
Bank
-
Legal Advisor
-
cardiocore lab ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to cardiocore lab ltd.
cardiocore lab ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CARDIOCORE LAB LTD. This can take several minutes, an email will notify you when this has completed.
cardiocore lab ltd Companies House Filings - See Documents
date | description | view/download |
---|